Seres Therapeutics, Inc. (MCRB)
NASDAQ: MCRB · Real-Time Price · USD
4.480
-0.240 (-5.08%)
At close: Aug 13, 2026, 4:00 PM EDT
4.450
-0.030 (-0.67%)
After-hours: Aug 13, 2026, 7:34 PM EDT
Seres Therapeutics Employees
Seres Therapeutics had 66 employees as of December 31, 2025. The number of employees decreased by 37 or -35.92% compared to the previous year.
Employees
66
Change (1Y)
-37
Growth (1Y)
-35.92%
Revenue / Employee
$28,530
Profits / Employee
-$340,348
Market Cap
44.54M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 66 | -37 | -35.92% |
| Dec 31, 2024 | 103 | -130 | -55.79% |
| Dec 31, 2023 | 233 | -198 | -45.94% |
| Dec 31, 2022 | 431 | 98 | 29.43% |
| Dec 31, 2021 | 333 | 178 | 114.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Karyopharm Therapeutics | 228 |
| Metagenomi Therapeutics | 118 |
| Aligos Therapeutics | 82 |
| Filana Therapeutics | 20 |
| Veru Inc. | 20 |
| Serina Therapeutics | 16 |
| CervoMed | 15 |
| Context Therapeutics | 15 |
MCRB News
- 11 hours ago - Seres Therapeutics Registration statement: Registration filing - Filings
- 8 days ago - Seres Therapeutics reports Q2 EPS 47c, consensus ($2.18) - TheFly
- 8 days ago - Seres Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updates, Including Further Action to Reduce Ongoing Facilities Costs - GlobeNewsWire
- 8 days ago - Seres Therapeutics Earnings release: Q2 2026 - Filings
- 8 days ago - Seres Therapeutics Quarterly report: Q2 2026 - Filings
- 5 weeks ago - Seres Therapeutics Transcript: Study result - Transcripts
- 5 weeks ago - Seres Therapeutics Press release: Study result - Filings
- 5 weeks ago - Seres Therapeutics Slides: Study result - Filings